Danone finishes Medical Nutrition acquisition
This article was originally published in The Tan Sheet
Executive Summary
Medical Nutrition USA becomes Danone North America's wholly owned subsidiary July 22, with $4 paid for each outstanding share. Danone looks to become more competitive in the long-term care product category, where it competes primarily with Nestle. The takeover was announced June 11 to some outcry, as lawyers investigating the deal claimed stockholders did not get a fair deal. They argued the company, which posted a 29.7 percent increase in net sales in the preceding quarter, should have held out for a larger offer 1("The Tan Sheet" June 21, 2010)
You may also be interested in...
Danone Shakes Up Elderly Care Market With Offer For Medical Nutrition USA
Danone's $62.3 million bid for Medical Nutrition USA will boost the French firm's U.S. nutritional product business, but securities litigators fishing for clients say the deal may shortchange MN shareholders
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.